Significant Disparities in Access to Novel Agents For Patients With Melanoma

October 9, 2016
Lidija Kandolf Sekulovic, MD, PhD

Lidija Kandolf Sekulovic, MD, PhD, associate professor of Dermatology, Military Medical Academy in Belgrade, Serbia, discusses a recently published survey during an interview at the 2016 ESMO Congress. The survey found that several thousand patients with metastatic melanoma in Europe do not have access to new, life-saving agents in this field.